All In Biotech

Drug Trial Radar · NCT02413268

Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

Last checked: Nov 19, 2026Latest source record: Sep 17, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 2,400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,400

Planned (sponsor's estimate)

Start

Mar 2016

Primary completion

Jul 2020

Study completion Jul 2020

Sponsor

Lead sponsor
Total Cardiovascular SolutionsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 9, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized comparison of topical nitroglycerin versus placebo gel for prevention of radial artery occlusion after transradial catheterization.

Conditions

  • Total Atherosclerotic Occlusion of Radial Artery

Interventions

  • NitroglycerinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Radial Artery OcclusionTime frame: up to 2 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Apex Heart Institute

    Ahmedabad, Gujarat, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.